EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 26 April 2024. Database contains 4691 unique substances/entries.

Filter the list

Showing 1,501 - 1,600 of 4,691 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC
N-methylformamide	204-624-6	123-39-7	Repr. 1B; Acute Tox. 4
N-methylbenzene-1,2-diammonium hydrogen phosphate	424-460-0	283167-56-6	Acute Tox. 4; Skin Sens. 1
N-methylaniline	202-870-9	100-61-8	Acute Tox. 3; STOT RE 2
N-methylacetamide	201-182-6	79-16-3	Repr. 1B
N-methyl-p-toluidine	210-769-6	623-08-5	Acute Tox. 3; STOT RE 2
N-methyl-o-toluidine	210-260-9	611-21-2	Acute Tox. 3; STOT RE 2
N-methyl-N-cyanomethylmorpholiniummethylsulfate	429-340-1	186295-11-4	Acute Tox. 4; Eye Dam. 1
N-methyl-N-2,4,6-tetranitroaniline; tetryl	207-531-9	479-45-8	Expl. 1.1; Acute Tox. 3; STOT RE 2
N-methyl-m-toluidine	211-795-0	696-44-6	Acute Tox. 3; STOT RE 2
N-methyl-4-(p-formylstyryl)pyridinium methylsulfate N-METHYL-4-(P-FORMYLSTYRYL)-PYRIDINIUM METHYLSULFATE; SBQ; SBQ-SALZ	418-240-3	74401-04-0	Skin Sens. 1
N-methyl-2-pyrrolidone; 1-methyl-2-pyrrolidone	212-828-1	872-50-4	Repr. 1B; STOT SE 3; Skin Irrit. 2; Eye Irrit. 2
N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)- 1-methylpyrazole-4-carboxamide; pydiflumetofen	817-852-1	1228284-64-7	Carc. 2; Repr. 2
N-isopropyl-N'-phenyl-p-phenylenediamine	202-969-7	101-72-4	Acute Tox. 4; Skin Sens. 1
n-hexyllithium N-HEXYLLITHIUM	404-950-0	21369-64-2	Water-react. 1; Pyr. Sol. 1; Skin Corr. 1A
n-hexane	203-777-6	110-54-3	Flam. Liq. 2; Repr. 2; Asp. Tox. 1; STOT RE 2; Skin Irrit. 2; STOT SE 3
N-hexadecyl(or octadecyl)-N-hexadecyl (or octadecyl)benzamide DTBA	401-980-6	-	Skin Irrit. 2; Skin Sens. 1
N-ethylaniline	203-135-5	103-69-5	Acute Tox. 3; STOT RE 2
N-ethyl-N-methylpiperidinium iodide CATALYST 4017	407-780-5	4186-71-4	Acute Tox. 4
N-ethyl-3-trimethoxysilyl-2-methyl-propanamine	437-720-3	227085-51-0	Eye Dam. 1
N-ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one	220-250-6	2687-91-4	Repr. 1B
N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate DIMETHYLPAPAMIDOLAURDIMONIUM TOSYLATE	421-130-8	156679-41-3	Eye Dam. 1; Skin Sens. 1
N-cyclohexylbenzothiazole-2- sulphenamide	202-411-2	95-33-0	Skin Sens. 1
N-cyclohexyl-S, S-dioxo; benzo[b]tiophene-2-carboxamide PREVENTOL VP OC 3061	423-990-1	149118-66-1	Acute Tox. 4; Eye Dam. 1
N-carboxymethyliminobis(ethylenenitrilo)tetra (acetic acid)	200-652-8	67-43-6	Repr. 1B; Acute Tox. 4; STOT RE 2; Eye Irrit. 2
n-butyronitrile	203-700-6	109-74-0	Flam. Liq. 2; Acute Tox. 3
N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide DISPERSOL YELLOW XF	407-970-8	75511-91-0	Skin Sens. 1
N-butyl-2-(4-morpholinylcarbonyl)benzamide EP 389	407-730-2	104958-67-0	Eye Irrit. 2; Skin Sens. 1
n-butyl propionate	209-669-5	590-01-2	Flam. Liq. 3
n-butyl methacrylate	202-615-1	97-88-1	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
n-butyl acrylate	205-480-7	141-32-2	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
n-butyl acetate	204-658-1	123-86-4	Flam. Liq. 3; STOT SE 3
N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine	425-300-2	186450-73-7	Skin Sens. 1
N-amidino-N-methylglycine-2-oxopropionate	429-120-5	208535-04-0	Eye Dam. 1
N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide	424-550-1	84245-12-5	Carc. 1B; Muta. 1B; Repr. 1B
N-[4-cyano-3-trifluoromethylphenyl]methacrylamide	427-880-2	90357-53-2	STOT RE 2
N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide BENZANILID-DISPERSE-INTERMEDIATE ZP 9955	411-590-8	70693-57-1	Skin Corr. 1B
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide	423-530-8	152828-23-4	STOT RE 1; Acute Tox. 4
N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate DS 100	415-060-7	1379678-87-1	Eye Dam. 1; Skin Sens. 1
N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide DISPERSOL BLUE C-4G COLOUR; SUBSTANCE H87919	416-860-9	777891-21-1	Repr. 2; Skin Sens. 1
N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-N-carboxyanhydride	430-360-8	84793-24-8	Eye Dam. 1; Skin Sens. 1
N-[(benzotriazole-1-yl)methyl)]4-carboxy-benzenesulfonamide BTAD	416-470-9	170292-97-4	Eye Irrit. 2
N-2-naphthylaniline; N-phenyl-2-naphthylamine	205-223-9	135-88-6	Carc. 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
N-(n-octyl)-2-pyrrolidone NOP; SURFADONE LP-100 SURFACTANT	403-700-8	2687-94-7	Skin Corr. 1B
N-(hydroxymethyl)acrylamide; methylolacrylamide; [NMA]	213-103-2	924-42-5	Carc. 1B; Muta. 1B; STOT RE 1
N-(dichlorofluoromethylthio)phthalimide; N-(fluorodichloromethylthio)phthalimide	211-952-3	719-96-0	Skin Irrit. 2
N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide TSD-40	413-200-1	129604-78-0	Skin Sens. 1
N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide; isoflucypram	811-438-4	1255734-28-1	Repr. 2; Acute Tox. 4; Skin Sens. 1B
N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide UC-129	403-790-9	108673-51-4	Skin Sens. 1
N-(2-nitrophenyl)phosphoric triamide	477-690-9	874819-71-3	Repr. 1B; STOT RE 2
N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide	425-650-6	171887-03-9	Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide UM-229	407-070-5	142859-67-4	Skin Sens. 1
N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate; 4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate	247-161-5	25646-71-3	Acute Tox. 4; Skin Sens. 1
N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide; (4-acetamido-2,2,6,6-tetra; methyl-1-piperidinyl)oxidanyl	423-840-3	14691-89-5	Acute Tox. 4
N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride PPX-HCL	417-950-0	65797-42-4	Acute Tox. 4
N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine	429-640-2	52870-46-9	Eye Irrit. 2
N,N-dimethylhydrazine	200-316-0	57-14-7	Flam. Liq. 2; Carc. 1B; Acute Tox. 3; Skin Corr. 1B
N,N-dimethylbenzene-1,3-diamine	220-623-3	2836-04-6	Acute Tox. 3
N,N-dimethylaniline	204-493-5	121-69-7	Carc. 2; Acute Tox. 3
N,N-dimethylacetamide	204-826-4	127-19-5	Repr. 1B; Acute Tox. 4
N,N-dimethyl-p-toluidine	202-805-4	99-97-8	Carc. 1B; Acute Tox. 4; Acute Tox. 3; STOT RE 2
N,N-dimethyl-o-toluidine	210-199-8	609-72-3	Acute Tox. 3; STOT RE 2
N,N-dimethyl-m-toluidine	204-495-6	121-72-2	Acute Tox. 3; STOT RE 2
N,N-diethylaniline	202-088-8	91-66-7	Acute Tox. 3; STOT RE 2
N,N-diethyl-m-toluamide; deet	205-149-7	134-62-3	Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide	431-530-4	1380226-29-8	Skin Corr. 1A; Skin Sens. 1
N,N,N-trimethylanilinium chloride	205-319-0	138-24-9	Acute Tox. 3
N,N,N,N-tetrakis(4,6-bis(butyl- (N-methyl-2,2,6,6-tetramethyl piperidin-4-yl)amino)triazin-2- yl)-4,7-diazadecane-1,10- diamine CHIMASSORB 119; LOWILITE 19	401-990-0	106990-43-6	Skin Sens. 1
N,N,N',N'-tetramethyl-4,4'-methylendianiline	202-959-2	101-61-1	Carc. 1B
N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane PFMT 1848	410-060-3	130728-76-6	Muta. 2; Skin Sens. 1
N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide LICHTSCHUTZMITTEL 1736	413-610-0	124172-53-8	Eye Irrit. 2
N,N'-methylenedimorpholine; N,N'-methylenebismorpholine [formaldehyde released from N,N'-methylenebismorpholine]; [MBM]	227-062-3	5625-90-1	Carc. 1B; Muta. 2; Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1; Eye Dam. 1
N,N'-dimethylbenzidine	-	2810-74-4	Acute Tox. 4
N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide QUESTAMIDE H	422-560-9	149591-38-8	Repr. 2; Eye Irrit. 2
N,N'-diacetylbenzidine	210-338-2	613-35-4	Carc. 1B; Muta. 2; Acute Tox. 4
N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt RED REN 363	419-500-9	171599-85-2	Eye Dam. 1; Skin Sens. 1
N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide NYLOSTAB S-EED; NYSEED	419-710-0	42774-15-2	Acute Tox. 4; Eye Irrit. 2
N, N-hydrazinodiacetic acid F.H.D.A.	403-510-5	19247-05-3	Acute Tox. 3; STOT RE 2; Skin Sens. 1
N, N-dimethylformamide; dimethyl formamide	200-679-5	68-12-2	Repr. 1B; Acute Tox. 4; Eye Irrit. 2
N, N-dimethylanilinium tetrakis(pentafluorophenyl)borate B1; N,N-DIMETHYLANILINUM TETRAKIS(PENTAFLUOROPHENYL)BORATE; TÉTRAKIS(PENTAFLUOROPHÉNYL)BORATE DE N,N-DIMÉTHYLANILINIUM	422-050-6	118612-00-3	Carc. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
N, N-dimethyl-2-(3-(4-chloro phenyl)-4,5-dihydropyrazol-1- ylphenylsulphonyl)ethylamine HOSTALUX VP 3481	401-410-6	10357-99-0	STOT RE 2; Skin Sens. 1
N, N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine DDPD	406-610-7	62478-82-4	Flam. Liq. 3; Acute Tox. 4; STOT RE 2; Skin Corr. 1A
N, N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide	418-290-6	168612-06-4	Eye Irrit. 2; Skin Sens. 1
N, N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane	445-890-5	201290-01-9	Acute Tox. 4; Skin Sens. 1
N, N-bis(3-aminopropyl)methylamine	203-336-8	105-83-9	Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B
N, N-bis(2-ethylhexyl)-((1,2,4- triazol-1-yl)methyl)amine CM 23-376; REOMET 30	401-280-0	91273-04-0	Skin Corr. 1B; Skin Sens. 1
N, N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide DIETHANOLAMIN-TRITOSYLAT	412-920-3	16695-22-0	Skin Sens. 1
N, N-(dimethylamino)thioacetamide hydrochloride	435-470-1	27366-72-9	Repr. 1B
N, N,N',N'-tetramethylethylenediamine	203-744-6	110-18-9	Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1B
N, N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride AF-172; FPC 114	405-300-9	17339-60-5	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
N, N,N',N'-tetramethyl-p-phenylenediamine	202-831-6	100-22-1	Acute Tox. 4
N, N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate CARTASOL BRILLIANT YELLOW K-6G; CARTASOL BRILLIANT YELLOW K-6G CONC.; GIALLO BRILLANTE CARTASOL K-6G CONC.; JAUNE BRILLANT CARTASOL K-RWA 3904; RWA 3904	403-340-1	164578-09-0	Eye Dam. 1
N, N'-ethylenebis(vinylsulfonylacetamide) H-603	404-790-1	66710-66-5	Eye Dam. 1; Skin Sens. 1
N, N'-diphenyl-p-phenylenediamine; N, N'-diphenyl-1,4-benzenediamine	200-806-4	74-31-7	Skin Sens. 1
N, N'-bis(trifluoroacetyl)-S, S'-bis-L-homocysteine BMS 208143-01; BTHC	429-670-6	105996-54-1	Eye Dam. 1; Skin Sens. 1
N, N'-(2,2-dimethylpropylidene)hexamethylenediamine LUPRAGEN VP 9159	401-660-6	1000-78-8	Skin Irrit. 2; Skin Sens. 1
N, N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine	435-010-8	26157-73-3	Muta. 2
N, N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea	430-930-6	122886-55-9	Eye Dam. 1; Resp. Sens. 1
N, N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]	429-380-1	133336-92-2	Skin Sens. 1
N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide	435-860-1	214417-91-1	Skin Sens. 1
Mycoplasma pneumoniae	-	-		B Bacteria and similar species

Showing 1,501 - 1,600 of 4,691 results.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 26 April 2024. Database contains 4691 unique substances/entries.

Footer Nav Items